Page results
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH Pain Management Centre is a nationally recognized centre of excellence for people with longstanding pain.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease. It outlines the importance of having your heart checked as part of your care.
-
UCLH will play a vital role in a new respiratory virus study.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
